SASevara B. Azimova

Sevara B. Azimova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sevara B. Azimova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endothelial dysfunction determines vascular mechanisms of metastatic progression in breast cancer

    by Matluba Mirzaeva, Akbarjon Mirzayev, Bakhtiyar Iriskulov, Sevara B. Azimova, Shamsiddin Nizamkhodjaev, Akmal M. Asrorov

    Breast cancer (BC) is one of the most common types of cancer among women, leading to death. More than 90% of deaths from BC are due to hematogenous metastases. In the cellular and tissue levels, the aggressiveness of BC is linked with epithelial–mesenchymal transition, leading to enhanced cell motility and spread in the bloodstream, leading to tumor expansion. This review focuses on the vascular mechanisms that facilitate metastatic dissemination in BC, highlighting the influence of blood vessels, hemodynamic forces, and vascular microenvironmental properties on tumor cell spread. Particular emphasis is placed on the role of endothelial dysfunction within common comorbid conditions and how these alterations may increase metastatic propensity. In addition, we discussed whether improving endothelial health and effectively managing comorbidities could help reduce metastatic progression.


  • SOD2 AND eNOS GENE POLYMORPHISMS AS PREDICTORS OF OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION IN CYTOMEGALOVIRUS INFECTION

    by Muzaffar Jo‘rAyev, Sevara Azimova, Eduard Vasilevskiy, Omonjon Dadaboyev

    Genotyping was performed in 100 patients with CMV infection (Group I - latent form, Group II - manifest persistent form) and 80 individuals of the control group. It was established that the Val/Val genotype of the SOD2 gene (39.6% vs. 22.5%; OR=2.27; p=0.03) and the T allele of the eNOS gene (36.2% vs. 19.4%; OR=2.47; p=0.001) are significantly associated with the risk of infection manifestation. The highest increase in the risk allele frequency was recorded for the SOD2 polymorphism (Δ16.3%), indicating the key role of antioxidant defense deficiency in the pathogenesis of persistence. The findings justify the inclusion of oxidative stress and endothelial dysfunction markers into a prognostic panel for assessing the risk of CMV progression.